Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

All Drugs Associated with Poor venous access (Page 2)

227 drugs have been associated with Poor venous access in FAERS reports.

Drug Reports Deaths Hosp. Life-Threat.
CAPECITABINE 29 1 2 0
DEXLANSOPRAZOLE 28 0 8 3
EFTRENONACOG ALFA 28 0 10 0
BEVACIZUMAB 26 5 8 1
COVID-19 VACCINE 25 2 13 1
PEMBROLIZUMAB 25 0 5 1
PAMIDRONATE 24 3 0 0
TEDUGLUTIDE 24 4 19 0
DIMETHYL 23 0 6 0
TRASTUZUMAB 23 0 10 1
EVEROLIMUS 22 0 0 0
INTERFERON BETA-1A 22 0 7 0
ANTIHEMOPHILIC FACTOR, PEGYLATED HUMAN SEQUENCE RECOMBINANT 21 0 2 0
CYCLOBENZAPRINE 21 0 21 0
ESOMEPRAZOLE 21 0 21 0
INFLIXIMAB-ABDA 21 0 6 1
LEVOFLOXACIN 21 0 19 1
AMLODIPINE 20 11 0 0
MESALAMINE 20 0 9 0
NAPROXEN 20 0 14 6
SIPULEUCEL-T 20 0 1 0
CYCLOSPORINE 19 0 2 0
EFMOROCTOCOG ALFA 19 0 5 0
GALSULFASE 19 0 5 0
GOLIMUMAB 19 0 5 0
IRON 19 2 13 0
LENALIDOMIDE 19 0 9 0
ORENCIA 19 0 0 0
PALBOCICLIB 19 1 12 1
PREGABALIN 19 0 5 0
AMOXICILLIN 18 0 17 0
GABAPENTIN 18 0 18 0
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN 18 3 7 1
PREDNISOLONE 18 0 2 0
AGALSIDASE ALFA 17 1 14 0
BELIMUMAB 17 0 1 0
EDARAVONE 17 2 3 0
LANADELUMAB-FLYO 17 0 11 3
PERTUZUMAB 17 0 7 0
RAMIPRIL 17 0 3 0
ANTIHEMOPHILIC FACTOR HUMAN 16 1 9 0
BEVACIZUMAB-BVZR 16 5 3 1
DIMENHYDRINATE 16 0 10 0
SEBELIPASE ALFA 16 0 4 1
SODIUM 16 1 6 0
USTEKINUMAB 16 0 1 0
LORAZEPAM 15 1 6 0
NIVOLUMAB 15 0 3 0
ONDANSETRON 15 0 0 0
OXALIPLATIN 15 0 0 1
« 1 2 3 4 5 »